The diabetic surgical patient

Vivek K. Moitra, Steffen E. Meiler

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: This review summarizes the current progress in disease classification, pathophysiology and management of diabetes mellitus with a special focus on treatment modalities and recommendations for the practicing anesthesiologist. RECENT FINDINGS: The revised classification of diabetes mellitus emphasizes disease cause and eliminates any reference to age-of-onset and insulin therapy. Hyperglycemia has emerged as an important marker of outcome in the operating room. Intensive insulin therapy promises to reduce health risk in the surgical and critical care setting. Perioperative β-blocker and statin therapy are likely to reduce cardiac morbidity and mortality in diabetic patients. Promotility therapy (with metoclopromide) intended to reduce the aspiration risk of diabetic gastroparesis is likely over-utilized and may only be indicated for diabetics with poor glucose control and high hemoglobin A1c levels. SUMMARY: According to World Health Organization projections, anesthesiologists can expect to care for more diabetic patients than ever before. Diabetes and its associated complications present unique challenges to the perioperative physician. As biomedical research continues to unravel the genetic, cellular and molecular mechanisms of this complex metabolic disease, our specialty must be prominently involved in the design and testing of innovative treatments to protect the diabetic patient from the risks of surgery and anesthesia.

Original languageEnglish (US)
Pages (from-to)339-345
Number of pages7
JournalCurrent Opinion in Anaesthesiology
Volume19
Issue number3
DOIs
StatePublished - Jun 1 2006

Fingerprint

Diabetes Mellitus
Therapeutics
Insulin
Gastroparesis
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Metabolic Diseases
Operating Rooms
Critical Care
Age of Onset
Hyperglycemia
Biomedical Research
Molecular Biology
Hemoglobins
Anesthesia
Morbidity
Physicians
Glucose
Mortality
Health
Anesthesiologists

Keywords

  • Anesthesiology
  • Diabetes
  • Hyperglycemia
  • Outcome
  • Perioperative

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The diabetic surgical patient. / Moitra, Vivek K.; Meiler, Steffen E.

In: Current Opinion in Anaesthesiology, Vol. 19, No. 3, 01.06.2006, p. 339-345.

Research output: Contribution to journalReview article

Moitra, Vivek K. ; Meiler, Steffen E. / The diabetic surgical patient. In: Current Opinion in Anaesthesiology. 2006 ; Vol. 19, No. 3. pp. 339-345.
@article{4e76b134201144319f28504e5a8b14a8,
title = "The diabetic surgical patient",
abstract = "PURPOSE OF REVIEW: This review summarizes the current progress in disease classification, pathophysiology and management of diabetes mellitus with a special focus on treatment modalities and recommendations for the practicing anesthesiologist. RECENT FINDINGS: The revised classification of diabetes mellitus emphasizes disease cause and eliminates any reference to age-of-onset and insulin therapy. Hyperglycemia has emerged as an important marker of outcome in the operating room. Intensive insulin therapy promises to reduce health risk in the surgical and critical care setting. Perioperative β-blocker and statin therapy are likely to reduce cardiac morbidity and mortality in diabetic patients. Promotility therapy (with metoclopromide) intended to reduce the aspiration risk of diabetic gastroparesis is likely over-utilized and may only be indicated for diabetics with poor glucose control and high hemoglobin A1c levels. SUMMARY: According to World Health Organization projections, anesthesiologists can expect to care for more diabetic patients than ever before. Diabetes and its associated complications present unique challenges to the perioperative physician. As biomedical research continues to unravel the genetic, cellular and molecular mechanisms of this complex metabolic disease, our specialty must be prominently involved in the design and testing of innovative treatments to protect the diabetic patient from the risks of surgery and anesthesia.",
keywords = "Anesthesiology, Diabetes, Hyperglycemia, Outcome, Perioperative",
author = "Moitra, {Vivek K.} and Meiler, {Steffen E.}",
year = "2006",
month = "6",
day = "1",
doi = "10.1097/01.aco.0000192820.76353.3e",
language = "English (US)",
volume = "19",
pages = "339--345",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The diabetic surgical patient

AU - Moitra, Vivek K.

AU - Meiler, Steffen E.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - PURPOSE OF REVIEW: This review summarizes the current progress in disease classification, pathophysiology and management of diabetes mellitus with a special focus on treatment modalities and recommendations for the practicing anesthesiologist. RECENT FINDINGS: The revised classification of diabetes mellitus emphasizes disease cause and eliminates any reference to age-of-onset and insulin therapy. Hyperglycemia has emerged as an important marker of outcome in the operating room. Intensive insulin therapy promises to reduce health risk in the surgical and critical care setting. Perioperative β-blocker and statin therapy are likely to reduce cardiac morbidity and mortality in diabetic patients. Promotility therapy (with metoclopromide) intended to reduce the aspiration risk of diabetic gastroparesis is likely over-utilized and may only be indicated for diabetics with poor glucose control and high hemoglobin A1c levels. SUMMARY: According to World Health Organization projections, anesthesiologists can expect to care for more diabetic patients than ever before. Diabetes and its associated complications present unique challenges to the perioperative physician. As biomedical research continues to unravel the genetic, cellular and molecular mechanisms of this complex metabolic disease, our specialty must be prominently involved in the design and testing of innovative treatments to protect the diabetic patient from the risks of surgery and anesthesia.

AB - PURPOSE OF REVIEW: This review summarizes the current progress in disease classification, pathophysiology and management of diabetes mellitus with a special focus on treatment modalities and recommendations for the practicing anesthesiologist. RECENT FINDINGS: The revised classification of diabetes mellitus emphasizes disease cause and eliminates any reference to age-of-onset and insulin therapy. Hyperglycemia has emerged as an important marker of outcome in the operating room. Intensive insulin therapy promises to reduce health risk in the surgical and critical care setting. Perioperative β-blocker and statin therapy are likely to reduce cardiac morbidity and mortality in diabetic patients. Promotility therapy (with metoclopromide) intended to reduce the aspiration risk of diabetic gastroparesis is likely over-utilized and may only be indicated for diabetics with poor glucose control and high hemoglobin A1c levels. SUMMARY: According to World Health Organization projections, anesthesiologists can expect to care for more diabetic patients than ever before. Diabetes and its associated complications present unique challenges to the perioperative physician. As biomedical research continues to unravel the genetic, cellular and molecular mechanisms of this complex metabolic disease, our specialty must be prominently involved in the design and testing of innovative treatments to protect the diabetic patient from the risks of surgery and anesthesia.

KW - Anesthesiology

KW - Diabetes

KW - Hyperglycemia

KW - Outcome

KW - Perioperative

UR - http://www.scopus.com/inward/record.url?scp=33744998676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744998676&partnerID=8YFLogxK

U2 - 10.1097/01.aco.0000192820.76353.3e

DO - 10.1097/01.aco.0000192820.76353.3e

M3 - Review article

C2 - 16735820

AN - SCOPUS:33744998676

VL - 19

SP - 339

EP - 345

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 3

ER -